Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.J Clin Microbiol. 2020 Jul 23; 58(8)JC
Links
MeSH
Pub Type(s)
Comparative Study
Evaluation Study
Letter
Language
eng
PubMed ID
32444354
Citation
Broder, Kari, et al. "Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges." Journal of Clinical Microbiology, vol. 58, no. 8, 2020.
Broder K, Babiker A, Myers C, et al. Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges. J Clin Microbiol. 2020;58(8).
Broder, K., Babiker, A., Myers, C., White, T., Jones, H., Cardella, J., Burd, E. M., Hill, C. E., & Kraft, C. S. (2020). Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges. Journal of Clinical Microbiology, 58(8). https://doi.org/10.1128/JCM.01187-20
Broder K, et al. Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges. J Clin Microbiol. 2020 Jul 23;58(8) PubMed PMID: 32444354.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.
AU - Broder,Kari,
AU - Babiker,Ahmed,
AU - Myers,Charles,
AU - White,Terri,
AU - Jones,Heather,
AU - Cardella,John,
AU - Burd,Eileen M,
AU - Hill,Charles E,
AU - Kraft,Colleen S,
Y1 - 2020/07/23/
PY - 2020/5/24/pubmed
PY - 2020/8/5/medline
PY - 2020/5/24/entrez
KW - COVID-19
KW - RT-PCR
KW - SARS-CoV-2
KW - diagnostics
KW - virology
JF - Journal of clinical microbiology
JO - J Clin Microbiol
VL - 58
IS - 8
SN - 1098-660X
UR - https://www.unboundmedicine.com/medline/citation/32444354/Test_Agreement_between_Roche_Cobas_6800_and_Cepheid_GeneXpert_Xpress_SARS_CoV_2_Assays_at_High_Cycle_Threshold_Ranges_
DB - PRIME
DP - Unbound Medicine
ER -